Canada markets close in 3 hours 46 minutes

Monte Rosa Therapeutics, Inc. (GLUE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.52-0.42 (-6.99%)
As of 12:05PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
78,323
111,272
85,061
57,155
24,005
Selling General and Administrative
24,959
32,039
27,323
15,727
4,005
Total Operating Expenses
103,282
143,311
112,384
72,882
28,010
Operating Income or Loss
-103,282
-143,311
-112,384
-72,882
-28,010
Total Other Income/Expenses Net
336
-1,037
119
-1,122
-7,878
Income Before Tax
-101,159
-135,014
-108,501
-73,958
-35,879
Income Tax Expense
338
338
0
-
-
Income from Continuing Operations
-101,159
-135,352
-108,501
-73,958
-35,879
Net Income
-101,159
-135,352
-108,501
-73,958
-35,879
Net Income available to common shareholders
-101,159
-135,352
-108,501
-73,958
-35,879
Basic EPS
-2.30
-
-2.30
-2.96
-1.65
Diluted EPS
-2.30
-
-2.30
-2.96
-1.65
Basic Average Shares
47,227
-
47,227
25,000
21,738
Diluted Average Shares
47,227
-
47,227
25,000
21,738